Gorlin Syndrome (Basal Cell Nevus
Syndrome) Market Pipeline Review Report
2017
“The latest Pharmaceutical and Healthcare disease
pipeline guide Gorlin Syndrome (Basal Cell Nevus
Syndrome) - Pipeline Review, H1 2017, provides an
overview of the Gorlin Syndrome (Basal Cell Nevus
Syndrome) (Genetic Disorders) pipeline landscape.”
Summary
The latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Basal Cell Nevus
Syndrome) - Pipeline Review, H1 2017, provides an overview of the Gorlin Syndrome (Basal Cell
Nevus Syndrome) (Genetic Disorders) pipeline landscape.
Gorlin syndrome, also known as nevoid basal cell carcinoma syndrome, is a condition that affects
many areas of the body and increases the risk of developing various cancerous and noncancerous
tumors. Symptoms include arrhythmia, medulloblastoma, ovarian fibromas, depressions in the skin,
large head size and skeletal abnormalities involving the spine, ribs, or skull. Treatment includes
surgery, radiotherapy and chemotherapy.
Complete Report Available @ http://www.radiantinsights.com/research/gorlin-
syndrome-basal-cell-nevus-syndrome-pipeline-review-h1-2017
Report Highlights
The Pharmaceutical and Healthcare latest pipeline guide Gorlin Syndrome (Basal Cell Nevus
Syndrome) - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics
Follow Us: